News

Biotech company Regeneron buying 23andMe for $256 million
The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
23andMe sells gene-testing business to DNA drug maker Regeneron
Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million ...
Struggling DNA testing firm 23andMe to be bought for $256m
The DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m ...
Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
Genetic data will be safeguarded with 23andMe sale, drugmaker vows
The deal would put the DNA data of millions of customers in the hands of a pharmaceutical company, which hopes to supercharge ...
Explore more
Stock Movers: 23andMe, Reddit, Royal Caribbean
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...